Name: Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132]
Brand: RabMAb
SKU: ab32101
Rating: 3 (4 reviews)

Product price, shipping and contact information

Currently unavailable

Sorry, we can't display this right now.

Please contact us to place your order, or try again later.

Loading size & price…

Abpromise

Guaranteed product quality, expert customer support.

Find out more.

Western blot - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

Key features and details

Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
Rabbit monoclonal [E132] to JAK2 (phospho Y1007 + Y1008)
Suitable for: ELISA, WB, ICC/IF, Flow Cyt, IHC-P, Dot blot
Reacts with: Human

Product name

Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132]
See all JAK2 primary antibodies
Description

Rabbit monoclonal [E132] to JAK2 (phospho Y1007 + Y1008)
Host species

Rabbit
Specificity

The antibody is phospho-specific and only detects phosphorylated JAK2 on Tyrosine 1007 and 1008 (pY1007+Y1008). According to our ELISA results, this antibody preferentially recognizes phospho Y1007. Stimulation may be required to allow detection of the phosphorylated protein. Please see images below for recommended treatment conditions and positive controls.

Tested Applications & Species

Application	Species
Dot	Human
Flow Cyt	Human
ICC/IF	Human
IHC-P	Human
WB	Human

See all applications and species data

Immunogen

Synthetic peptide within Human JAK2 (phospho Y1007 + Y1008). The exact sequence is proprietary.
Positive control
- WB: Jurkat or K562 cells (treated with Pervanadate). IHC-P: Human lung adenocarcinoma tissue. ICC/IF: Jurkat cells (treated with Pervanadate). Flow Cyt: Jurkat starved of serum for 16 hours then treated with 1mM Pervanadate for 30 minutes.
General notes
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free production
For more information see here.
Our RabMAb^® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb^® patents.

Form

Liquid
Storage instructions

Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Avoid freeze / thaw cycle.
Storage buffer

pH: 7.20
Preservative: 0.01% Sodium azide
Constituents: 49% PBS, 50% Glycerol (glycerin, glycerine), 0.05% BSA
Concentration information loading...
Purity

Protein A purified
Clonality

Monoclonal
Clone number

E132
Isotype

IgG
Research areas

Alternative Versions
Compatible Secondaries
- Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (ab150077)
Isotype control
- Rabbit IgG, monoclonal [EPR25A] - Isotype Control (ab172730)
Recombinant Protein
- Recombinant human JAK2 protein (ab42619)
Related Products
- Prestained Protein Ladder - Broad molecular weight (10-245 kDa) (ab116028)

The Abpromise guarantee

Our Abpromise guarantee covers the use of ab32101 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Guaranteed

Tested applications are guaranteed to work and covered by our Abpromise guarantee.

Predicted

Predicted to work for this combination of applications and species but not guaranteed.

Incompatible

Does not work for this combination of applications and species.

Application	Species
Dot	Human
Flow Cyt	Human
ICC/IF	Human
IHC-P	Human
WB	Human
All applications	Mouse Rat

Application	Abreviews	Notes
ELISA		Use at an assay dependent concentration.
WB	(3)	1/1000 - 1/10000. Detects a band of approximately 120 kDa (predicted molecular weight: 130 kDa). The samples may require stimulation (E.g., Jurkat cells treated with pervanadate for 5 min)
ICC/IF	(1)	1/1000.
Flow Cyt		1/20.
IHC-P		Use at an assay dependent concentration. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Dot blot		1/1000.

Notes
ELISA Use at an assay dependent concentration.
WB 1/1000 - 1/10000. Detects a band of approximately 120 kDa (predicted molecular weight: 130 kDa). The samples may require stimulation (E.g., Jurkat cells treated with pervanadate for 5 min)
ICC/IF 1/1000.
Flow Cyt 1/20.
IHC-P Use at an assay dependent concentration. Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Dot blot 1/1000.

Function

Non-receptor tyrosine kinase involved in various processes such as cell cycle progression, apoptosis, mitotic recombination, genetic instability and histone modifications. In the cytoplasm, plays a pivotal role in signal transduction via its association with cytokine receptors, which constitutes an initiating step in signaling for many members of the cytokine receptor superfamily including the receptors for growth hormone (GHR), prolactin (PRLR), leptin (LEPR), erythropoietin (EPOR), granulocyte-macrophage colony-stimulating factor (CSF2), thrombopoietin (THPO) and multiple interleukins. Following stimulation with erythropoietin (EPO) during erythropoiesis, it is autophosphorylated and activated, leading to its association with erythropoietin receptor (EPOR) and tyrosine phosphorylation of residues in the EPOR cytoplasmic domain. Also involved in promoting the localization of EPOR to the plasma membrane. Also acts downstream of some G-protein coupled receptors. Plays a role in the control of body weight (By similarity). Mediates angiotensin-2-induced ARHGEF1 phosphorylation. In the nucleus, plays a key role in chromatin by specifically mediating phosphorylation of 'Tyr-41' of histone H3 (H3Y41ph), a specific tag that promotes exclusion of CBX5 (HP1 alpha) from chromatin.
Tissue specificity

Expressed in blood, bone marrow and lymph node.
Involvement in disease

Note=Chromosomal aberrations involving JAK2 are found in both chronic and acute forms of eosinophilic, lymphoblastic and myeloid leukemia. Translocation t(8;9)(p22;p24) with PCM1 links the protein kinase domain of JAK2 to the major portion of PCM1. Translocation t(9;12)(p24;p13) with ETV6.
Defects in JAK2 are a cause of susceptibility to Budd-Chiari syndrome (BCS) [MIM:600880]. It is a syndrome caused by obstruction of hepatic venous outflow involving either the hepatic veins or the terminal segment of the inferior vena cava. Obstructions are generally caused by thrombosis and lead to hepatic congestion and ischemic necrosis. Clinical manifestations observed in the majority of patients include hepatomegaly, right upper quadrant pain and abdominal ascites. Budd-Chiari syndrome is associated with a combination of disease states including primary myeloproliferative syndromes and thrombophilia due to factor V Leiden, protein C deficiency and antithrombin III deficiency. Budd-Chiari syndrome is a rare but typical complication in patients with polycythemia vera.
Defects in JAK2 are a cause of polycythemia vera (PV) [MIM:263300]. A myeloproliferative disorder characterized by abnormal proliferation of all hematopoietic bone marrow elements, erythroid hyperplasia, an absolute increase in total blood volume, but also by myeloid leukocytosis, thrombocytosis and splenomegaly.
Defects in JAK2 gene may be a cause of essential thrombocythemia (ET) [MIM:187950]. ET is characterized by elevated platelet levels due to sustained proliferation of megakaryocytes, and frequently lead to thrombotic and haemorrhagic complications.
Defects in JAK2 are a cause of myelofibrosis (MYELOF) [MIM:254450]. Myelofibrosis is a disorder characterized by replacement of the bone marrow by fibrous tissue, occurring in association with a myeloproliferative disorder. Clinical manifestations may include anemia, pallor, splenomegaly, hypermetabolic state, petechiae, ecchymosis, bleeding, lymphadenopathy, hepatomegaly, portal hypertension.
Defects in JAK2 are a cause of acute myelogenous leukemia (AML) [MIM:601626]. AML is a malignant disease in which hematopoietic precursors are arrested in an early stage of development.
Sequence similarities

Belongs to the protein kinase superfamily. Tyr protein kinase family. JAK subfamily.
Contains 1 FERM domain.
Contains 1 protein kinase domain.
Contains 1 SH2 domain.
Domain

Possesses 2 protein kinase domains. The second one probably contains the catalytic domain, while the presence of slight differences suggest a different role for protein kinase 1.
Post-translational
modifications

Autophosphorylated, leading to regulate its activity. Leptin promotes phosphorylation on tyrosine residues, including phosphorylation on Tyr-813. Autophosphorylation on Tyr-119 in response to EPO down-regulates its kinase activity. Autophosphorylation on Tyr-868, Tyr-966 and Tyr-972 in response to growth hormone (GH) are required for maximal kinase activity.
Cellular localization

Endomembrane system. Nucleus.
Target information above from: UniProt accession O60674 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010) .

Information by UniProt
Database links
- Entrez Gene: 3717 Human
- Entrez Gene: 16452 Mouse
- Entrez Gene: 24514 Rat
- Omim: 147796 Human
- SwissProt: O60674 Human
- SwissProt: Q62120 Mouse
- SwissProt: Q62689 Rat
- Unigene: 656213 Human
- Unigene: 275839 Mouse
- Unigene: 18909 Rat
see all
Alternative names
- JAK 2 antibody
- JAK-2 antibody
- JAK2 antibody
- JAK2_HUMAN antibody
- Janus Activating Kinase 2 antibody
- Janus kinase 2 (a protein tyrosine kinase) antibody
- Janus kinase 2 antibody
- JTK 10 antibody
- JTK10 antibody
- kinase Jak2 antibody
- OTTHUMP00000043260 antibody
- THCYT3 antibody
- Tyrosine protein kinase JAK2 antibody
- Tyrosine-protein kinase JAK2 antibody
see all

Western blot - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

All lanes : Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101) at 1/5000 dilution

Lane 1 : Untreated Jurkat cells whole cell lysates
Lane 2 : Jurkat cells were treated with 50mM Pervanadate for 5 minutes whole cell lysates
Lane 3 : Jurkat cells were treated with 50mM Pervanadate for 5 minutes whole cell lysates. Then the membrane was incubated with Alkaline phosphatase.

Lysates/proteins at 10 µg per lane.

Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution

Predicted band size: 130 kDa
Observed band size: 120 kDa
why is the actual band size different from the predicted?

Exposure time: 5 seconds

Blocking and diluting buffer 5% NFDM/TBST
Immunocytochemistry/ Immunofluorescence - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

Immunocytochemistry/Immunofluorescence analysis of Jurkat +/- pervanadate (1mM, 30min) and Jurkat + pervanadate (1mM, 30min) + LP cells labelling JAK2 (phospho Y1007 + Y1008) with ab32101 at a dilution of 1/1000. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.1% tritonX-100. ab150077 (goat anti-rabbit IgG Alexa Fluor^® 488) (1/1000) was used as the secondary antibody. The cells were co-stained with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor^® 594)) at a 1/200 dilution. Nuclei counterstained with DAPI (blue).
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

ab32101 showing positive staining in human lung adenocarcinoma tissue.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Dot Blot - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

Dot blot analysis of human JAK2 (phospho Y1007 & Y1008) phospho peptide (Lane 1), JAK2 (phospho Y1007) phospho peptide (Lane 2), JAK2 (phospho Y1008) phospho peptide (Lane 3) and JAK2 non-phospho peptide (Lane 4) labelling JAK2 (phospho Y1007 & Y1008) with ab32101 at a dilution of 1/1000.

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) was used as the secondary antibody at a dilution of 1/20,000.

Blocking/Dilution buffer: 5% NFDM/TBST.
Western blot - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

All lanes : Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101) at 1/1000 dilution

Lane 1 : Jurkat (Human T cell leukemia T lymphocyte) whole cell lysates
Lane 2 : Jurkat (Human T cell leukemia T lymphocyte) treated with 50mM Pervanadate for 5 minutes whole cell lysates

Lysates/proteins at 15 µg per lane.

Secondary
All lanes : Goat Anti-Rabbit IgG H&L (HRP) (ab97051) at 1/20000 dilution

Predicted band size: 130 kDa
Observed band size: 120 kDa why is the actual band size different from the predicted?
Additional bands at: 60 kDa. We are unsure as to the identity of these extra bands.

Blocking and diluting buffer: 5% NFDM/TBST

Exposure time:
Left image: 1 second
Right image: 5 minutes
Flow Cytometry - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

Flow Cytometry analysis of Jurkat (human acute T cell leukemia) cells starved of serum for 16 hours then treated with 1 mM Pervanadate for 30 minutes labeling JAK2 (phospho Y1007 + Y1008) with ab32101 at 1/20 dilution (10 ug/mL) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor^®488) at 1/2000 dilution was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) was used as the unlabeled control. Unstimulated Jurkat cells were used as a negative control (Green).
ELISA - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

Direct ELISA antigen dose-response curve using ab32101 at 0~1000 ng/mL. Antigen concentration of 100 ng/mL. An Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) (1/2500) was used as the secondary antibody.

This antibody preferentially recognizes phospho Y1007. When the concentration of peptides is higher than 100 ng/mL, it also recognizes phospho Y1008.
ELISA - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

Direct ELISA antigen dose-response curve using ab32101 at 0~1000 ng/mL. Antigen concentration of 10 ng/mL. An Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) (1/2500) was used as the secondary antibody.

This antibody preferentially recognizes phospho Y1007. When the concentration of peptides is lower than 10 ng/mL, it cannot recognize phospho Y1008.
Dot Blot - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

Analysis of immunogen phosphopeptide (human JAK2 (phospho Y1007 + Y1008)) (A) and non phosphopeptide (B). Antibody used at 1/1000 dilution.
Western blot - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)This image is courtesy of an anonymous Abreview

All lanes : Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101) at 1/2000 dilution

Lane 1 : Rat uterine cell line - whole cell lysate. Treated with 1µg/mL Prolactin for 0 hours.
Lane 2 : Rat uterine cell line - whole cell lysate. Treated with 1µg/mL Prolactin for 15 minutes.
Lane 3 : Rat uterine cell line - whole cell lysate. Treated with 1µg/mL Prolactin for 30 minutes.
Lane 4 : Rat uterine cell line - whole cell lysate. Treated with 1µg/mL Prolactin for 1 hour.
Lane 5 : Rat uterine cell line - whole cell lysate. Treated with 1µg/mL Prolactin for 2 hours.
Lane 6 : Rat uterine cell line - whole cell lysate. Treated with 1µg/mL Prolactin for 4 hours.
Lane 7 : Rat uterine cell line - whole cell lysate. Treated with 1µg/mL Prolactin for 6 hours.
Lane 8 : Rat uterine cell line - whole cell lysate. Treated with 1µg/mL Prolactin for 24 hours.

Lysates/proteins at 30 µg per lane.

Secondary
All lanes : An HRP-conjugated donkey anti-rabbit polyclonal. at 1/10000 dilution

Developed using the ECL technique.

Performed under reducing conditions.

Predicted band size: 130 kDa
Observed band size: 110 kDa why is the actual band size different from the predicted?
Additional bands at: 55 kDa (possible non-specific binding)

See Abreview
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

ab32101 showing positive staining in human ovarian carcinoma tissue.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

ab32101 showing positive staining in human cervical carcinoma tissue.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

ab32101 showing positive staining in human endometrial carcinoma tissue.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

ab32101 showing positive staining in human urinary bladder transitional carcinoma tissue.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132] (ab32101)

To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.

Click here to view the general protocols

Publishing research using ab32101? Please let us know so that we can cite the reference in this datasheet.

ab32101 has been referenced in 69 publications.

Yang Y et al. Silencing of AURKA augments the antitumor efficacy of the AURKA inhibitor MLN8237 on neuroblastoma cells. Cancer Cell Int 20:9 (2020). PubMed: 31920463
Liu YL et al. Ligustrazine reverts anthracycline chemotherapy resistance of human breast cancer by inhibiting JAK2/STAT3 signaling and decreasing fibrinogen gamma chain (FGG) expression. Am J Cancer Res 10:939-952 (2020). PubMed: 32266101
Liu Y et al. Chrysophanol protects PC12 cells against oxygen glucose deprivation-evoked injury by up-regulating miR-216a. Cell Cycle 19:1433-1442 (2020). PubMed: 32401588
Deng QF et al. Cyclooxygenase-2 mediates gefitinib resistance in non-small cell lung cancer through the EGFR/PI3K/AKT axis. J Cancer 11:3667-3674 (2020). PubMed: 32284763
Wang Y et al. A lipid-soluble extract of Pinellia pedatisecta Schott enhances antitumor T cell responses by restoring tumor-associated dendritic cell activation and maturation. J Ethnopharmacol 241:111980 (2019). PubMed: 31146000

View all Publications for this product

Customer reviews and Q&As

Show All Reviews Q&A

Submit a review Submit a question

1-10 of 10 Abreviews or Q&A

Application

Immunocytochemistry/ Immunofluorescence

Sample

Human Cell (C42B Prostate cancer cell line)

Permeabilization

Yes - 0.1% Triton X-100

Specification

C42B Prostate cancer cell line

Blocking step

BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: RT°C

Fixative

Paraformaldehyde

Abcam user community

Verified customer

Submitted Feb 12 2020

Application

Western blot

Sample

Human Cell lysate - whole cell (DU145 Prostate cancer cell line)

Gel Running Conditions

Reduced Denaturing

Loading amount

20 µg

Specification

DU145 Prostate cancer cell line

Blocking step

BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: RT°C

Abcam user community

Verified customer

Submitted Feb 05 2020

Question

I purchased 12 antibodies from your company.
Some didn't work and I need your help.

I used mouse liver tissue. I attached our lab's protocol.
Apply 25ug of protein in each well.
The gel I used is NuPAGE 4-12% Bis-Tris Gel.
I tried 1:1000 dilution of JAK2 and 1:5000 of phospho JAK2 in 5%NFDM TBST.
Both didn't work. No bands, even with 2 hour exposure.

Please give me your advice.

Abcam community

Verified customer

Asked on Nov 08 2012

Answer

Thank you for bringing this to our attention. I am sorry to read that two of the antibodies you purchased are not staining blots of your mouse liver samples.

I am assuming the transfer from gel to blot was effective, if your protocol worked with other blots of these samples.

I recommend stripping a blot and re-blocking with 1% BSA without detergent for one hour, and also diluting the antibodies in this 1% BSA solution, instead of non-fat dry milk. I also recommend trying the antibodies at higher concentrations, for instance 1/250 for anti-JAK2 ab39636, and 1/2000 for the phospho-Jak2 antibody, ab32101.

Please let me know the results. If this modification fails, I will be happy to provide replacements, or a credit or refund. The phosphorylation in the liver may be difficult to detect if it is not induced. If possible, I recommend including a positive control such as the treated mouse liver sample shown on the datasheet of ab68268.

Click here (or use the following: https://www.abcam.com/JAK2-phospho-Y1007--Y1008-antibody-ab68268.html).

Abcam Scientific Support

Answered on Nov 08 2012

Question

What is the conc of lot GR18831-6 (ab32101)

Abcam community

Verified customer

Asked on Jul 24 2012

Answer

Thank you for contacting us.

The concentration of lot GR57259-1 is XXXXXXX mg/ml.

I hope this information is helpful to you. Please do not hesitate to contact us if you need any more advice or information.

Use our products? Submit an Abreview. Earn rewards!
https://www.abcam.com/abreviews

Abcam Scientific Support

Answered on Jul 24 2012

Question

I am very interested in purchasing JAK2 (phospho Y1007 + Y1008)
antibody [E132] (ab32101) , but I would know whic positive control
(name of cell line, type and time of treatment) is used in western
blot image and moreover if this lysate is available by abcam,

thanks.

Abcam community

Verified customer

Asked on Mar 13 2012

Answer

Thank you for your enquiry.

I can confirm that this antibody has been tested on the following and these would be suitable positive controls:

Rat uterine cell line Treated with 1µg/mL Prolactin for 1 hour.

Jurkat cell lysate treated with GM-CSF (Granulocyte-macrophage colony-stimulating factor) or Pervanadate

I am sorry we do not provide lysates of these cell lines that have beenpre treated. Unfortunately, we did not test any cell lines that do not require pretreatment. I was not able to find positive controls for phosphorylated Jak2 in the literature, and from what I find stimulation is required for expression of this phosphorylated state of the protein in cell culture.

I can suggest to do a further literature search for more information.

I am sorry we have not suitable positive controls to provide from our catalog on this occasion, however I hope this information is useful to you. If you have any further questions, please do not hesitate to contact me.

Abcam Scientific Support

Answered on Mar 13 2012

Question

Haben Sie Erfahrungen zur Verwendung dieses AKs an Gefrierschnitten?

Abcam community

Verified customer

Asked on Dec 15 2011

Answer

Vielen Dank für Ihren Anruf und für Ihr Interesse an unseren Produkten. Gerne versichere ich Ihnen, dass alle unsere Produkte unsere Abcam Garantier unterliegen: Falls sich herausstellt, dass der Antikörper nicht so funktioniert, wie auf dem Datenblatt beschrieben und Sie sich innerhalb von sechs Monaten mit Ihrem Problem an uns wenden, werden wir Ihnen gerne Vorschläge zur Optimierung Ihres Protokolls oder gegebenenfalls einen Ersatz oder eine Gutschrift schicken. Wie am Telefon besprochen haben wir noch keine Abbildung von dem Antikörper ab32101 in der Immunhistochemie an Gefrierschnitten (IHC-Fr). Falls Sie uns eine Abbildung Ihrer Ergebnisse mit ab32101 zukommen lassen, kann ich Ihnen zurzeit ein spezielles Angebot über einen 100%igen Abreview-Rabatt anbieten. Bei diesem Angebot bekommen Sie einen Rabatt für eine zukünftige Bestellung, wenn Sie uns ein Abreview mit dem Testresultat und einer Abbildung zusenden. Der 100%ige Rabatt würde gegen eine erneute Bestellung eines primären Antikörpers von uns verrechnet werden. Um von diesem Angebot profitieren zu können, folgen Sie bitte diesen Schritten: 1.) Bestätigen Sie mir bitte, dass Sie ab32101 kaufen möchten und bereit sind uns eine Abbildung Ihrer Ergebnisse zukommen zu lassen. 2.) Bitte bestellen Sie erst nach Erhalt des Rabattcodes. 3.) Bestellen Sie den Antikörper wie üblich per Telefon, Email oder Fax 4.) Testen Sie den Antikörper in der IHC-Fr. 5.) Senden Sie uns die Abbildung Ihres Ergebnisses mittels eines Abreviews zu und notieren Sie den Discount Code in dem Feld "additional notes" Unter der folgenden URL können Sie mehr über unser Abreview System erfahren: https://www.abcam.com/abreviews 6.) Der Rabattcode ist nach dem Abschicken des Abreviews aktiv, und Sie können einen anderen primären Antikörper bei uns bestellen (halten Sie bei der Bestellung bitte den Rabattcode und die Bestellnummer bereit). Bitte beachten Sie, dass der Rabattcode innerhalb von 4 Monaten nach Ausstellung eingelöst werden muss. Der Rabattcode wird gültig unabhängig davon, ob Ihr Ergebnis positiv oder negativ ist. Die Bedingungen zu unserem 100% Abreview Rabatt können Sie unter dem folgenden Link nachlesen: https://www.abcam.com/collaborationdiscount Ich hoffe, diese Informationen helfen Ihnen weiter. Falls Sie einen Rabattcode erhalten möchten oder weitere Fragen haben, zögern Sie bitte nicht, sich wieder an mich zu wenden.

Abcam Scientific Support

Answered on Dec 15 2011

Question

I have a question regarding the treatment of tissue prior to applying the primary antibody. Do you recommend microwave? Enzymatic? The tissue I have in mind is human salivary gland. I'm planning to use ab6672, ab59389, ab39636, ab32101, ab31370 and ab30646. Different recommendations?

Abcam community

Verified customer

Asked on Sep 27 2011

Answer

Thank you for contacting us. The treatment of PFA-fixed, paraffin embedded sections (IHC-P) before incubation with priamry antibody would include antigen retrieval, blocking of endogenous peroxidases (if HRP is being used for detection), and blocking of non-specific proteins. Here are the protocol details for the respective antibodies: ab30646, ab31370, ab39636, ab59389: 1. antigen retrieval: 10 mM citrate buffer (pH6.0) boil in pressure cooker 2. block with 3% H2O2 (in fresh methanol) for 15 minutes at room temperature 3. block with 3% BSA in TBS for 30 minutes ab6672: antigen retrieval: citrate buffer pH 6 and proteinase K digestion have been tried successfully as well as no antigen retrieval. 2. block with 3% hydrogen peroxide for 10 min 3. block with 1-10% Serum for up to 1 hour ab32101: 1. antigen retrieval:10 mM Sodium Citrate Buffer, pH 6.0 in rice cooker 2. block with 3% hydrogen peroxide for 10 min 3. block with PBS + 10% serum I hope this information is helpful to you. Please do not hesitate to contact us if you need any more advice or information.

Abcam Scientific Support

Answered on Sep 27 2011

Application

Western blot

Sample

Rat Cell lysate - whole cell (Uterine Cell line)

Loading amount

30 µg

Specification

Uterine Cell line

Treatment

1ug/ml Prolactin

Gel Running Conditions

Reduced Denaturing (10)

Blocking step

Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 24°C

Abcam user community

Verified customer

Submitted Mar 19 2010

Application

Western blot

Sample

Human Cell lysate - whole cell (Lung)

Loading amount

10 µg

Specification

Lung

Treatment

10ng/mL IFN gamma for 24hrs

Gel Running Conditions

Reduced Denaturing

Blocking step

Milk as blocking agent for 18 hour(s) and 0 minute(s) · Concentration: 10% · Temperature: 4°C

Abcam user community

Verified customer

Submitted Jul 31 2007

Question

Dear Sirs, I am potentially very interested in purchasing this mAb but I would like first to know: 1) whether this mAb is specific for the Y1007-Y1008 phosphorylated form of JAK2 or also detects the non-phosphorylated form (could you please provide a western blot, as the one shown in the website is not informative in this regard?) 2) whether you had the chance to test this mAb also on formalin-fixed paraffin-embedded decalcified bone marrow biopsies; in fact, the additional decalcification step required by bone material often denatures epitopes otherwise resistant to formalin fixation and paraffin embedding 3) which tissues can be used as positive controls, besides lung adenocarcinoma 4) what is the frequency of positivity of lung adenocarcinoma ?

Abcam community

Verified customer

Asked on Oct 16 2006

Answer

Thank you for contacting us. In answer to your questions: 1. The antibody ab32101 is specific to the phosphorylated protein. We do not have another Western blot but we are confident, given the dot blot result, that this antibody will not recognize unphosphorylated JAK2. 2. We have not tested the antibody on bone marrow but our Abpromise guarantee covers this application. 3. Any carcinoma should serve well as a positive control: colon, breast, renal. 4. We do not know how often lung adenocarcinoma tissue reacts positively with this antibody. I hope this information helps. Please do not hesitate to contact us if you need any more advice or information.

Abcam Scientific Support

Answered on Oct 17 2006

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Key features and details

Overview

Product name

Description

Host species

Specificity

Tested Applications & Species

Immunogen

Positive control

General notes

Properties

Form

Storage instructions

Storage buffer

Purity

Clonality

Clone number

Isotype

Research areas

Associated products

Alternative Versions

Compatible Secondaries

Isotype control

Recombinant Protein

Related Products

Applications

The Abpromise guarantee

Target

Function

Tissue specificity

Involvement in disease

Sequence similarities

Domain

Post-translationalmodifications

Cellular localization

Database links

Alternative names

Images

Protocols

Datasheets and documents

References (69)

Customer reviews and Q&As

Immunocytochemistry/ Immunofluorescence abreview for Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132]

Western blot abreview for Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132]

Western blot abreview for Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132]

Western blot abreview for Anti-JAK2 (phospho Y1007 + Y1008) antibody [E132]

Post-translational
modifications